Reaction profile
The FDA adverse-event record for elevated symmetrical dimethylarginine (sdma)
1,964 FDA reports name elevated symmetrical dimethylarginine (sdma), a high-volume reaction in the CVM extract (VeDDRA 2583). Plate stamps and neighbourhood peers follow.
- #238 of 2,481
- by report volume (all reactions)
- 1,964
- reports citing this reaction
- 19.0%
- death-coded share
- Dog
- most-affected species
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Elevated symmetrical dimethylarginine (SDMA) has 1,964 reports now versus 1,864 in that prior snapshot: 100 more (5.4%).
- Report change
- +100
- Death-coded reports
- +14
- Death-coded share
- −0.3 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Elevated symmetrical dimethylarginine (SDMA) changesFDA AER · VeDDRA plate
Code 2583 VOL-MID
VOL-MID · DEATH-ELEV · TOP-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL
- VOL-MID 1,964 reports
- DEATH-ELEV 19.0%
- TOP-DECILE #238/2481
- PHOTO-FINISH Circling - neurologic…
- SPECIES-DOG Dog · 1,294
- DRUG-LEAD Bedinvetmab · 288
- DESK-WIDE 20 breeds
- BOOK-FULL 8/8 fields
Nearest volume peer: Circling - neurological disorder (see also 'Behavioural disorders') (±1 reports)
Upper-third report volume drives the scale stamps on this plate; death-coded share and co-report peers follow. Not a clinical diagnosis.
High-volume neighbourhood around Elevated symmetrical dimethylarginine
Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.
What the FDA AER plate says about Elevated symmetrical dimethylarginine (SDMA)
Signature read: 373 death-coded reports is a heavy tail count for Elevated symmetrical dimethylarginine (SDMA) in the CVM extract. Report volume is upper-third scale: 1,964 named reports in the openFDA extract. 373 of 1,964 reports were death-coded (19.0% of named reports, not a population mortality rate). Nearest volume peer: Circling - neurological disorder (see also 'Behavioural disorders') (±1 reports). Lead species Dog (1,294). Lead co-reported drug Bedinvetmab (288).
Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Bedinvetmab appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.
Species Most Affected
Breeds Most Affected
Associated Drugs
Nationwide reactions with similar profiles
Two openFDA-derived peer sets for Elevated symmetrical dimethylarginine (SDMA), both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).
Similar report volume
Nearest other reactions by FDA report count (1,964 here).
Similar death-coded share
Nearest other reactions by death-coded share (19.0% here), distinct from the volume row.
What to do with this reaction
- Compare Elevated symmetrical dimethylarginine's report profile against similar reactions nationwide. See similar reactions
- Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
- Browse the full reaction directory to compare report counts across reaction types. All reactions
A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →